Pioneering breakthrough treatments for common diseases
Founded in 2020 and headquartered in Cambridge, Massachusetts, Vesalius Therapeutics discovers and develops drugs by targeting biological circuits within cells to treat diseases underlying common illnesses such as Parkinson's disease. The company is backed by Flagship Pioneering and has a strategic alliance with GSK to develop novel Parkinson's disease treatments.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account